SAR-399063

N/A

Report date: 2022/01/07 11:27:29
NME

Base Information

Drug NameSAR-399063
Drug Alias NameDHA-GLP + vit DSAR-399063
ClassificationSmall molecules > Amino acid supplement, Lipids and Vitamins
Mechanisms of ActionInsulin release stimulants
TargetsInsulin receptor
Therapy Area/IndicationsSarcopenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsSarcopenia

Other Information

ATC CodeN/A
Related LinksN/A